Exciting news from Visiopharm - their Ki67 diagnostic App has received the CE mark for in-vitro diagnostic use in Europe. The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended...

Building on news from last year (see: Omnyx Acquires CE Mark in Europe), Omnyx recently announced more significant news with their approval for their Integrated Digital Pathology (IDP) solution with the new VL120 high volume scanner for...